Source: LawsuitGuru
On April 7, 2005, FDA announced several important changes that pertain to the marketing of non-steroidal anti-inflammatory drugs (NSAIDs). FDA has asked that one product be withdrawn from the market, and is requiring stronger warnings in the labeling for the other products.